Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Fundación Jiménez Díaz (34)

2024

  1. Biopsy-proven giant cell arteritis in an elderly woman diagnosed 11 years earlier with microscopic polyangiitis: two different vasculitides in the same patient separated in time

    Clinical and Experimental Rheumatology

  2. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

  3. Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19

    International Journal of Molecular Sciences, Vol. 25, Núm. 7

  4. Leflunomide as a therapeutic alternative to methotrexate as a glucocorticoid-sparing agent in polymyalgia rheumatica

    Rheumatology Advances in Practice

  5. Lights and shadows on the efficacy of tocilizumab monotherapy in large vessel giant cell arteritis

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 6-7

  6. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  7. The complement system is linked to insulin resistance in patients with systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121

  8. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

    RMD open, Vol. 10, Núm. 2

2023

  1. A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  2. Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis

    Journal of Clinical Medicine, Vol. 12, Núm. 9

  3. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  4. Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritis

    Expert Review of Clinical Immunology, Vol. 19, Núm. 5, pp. 517-526

  5. Classifying extracranial large-vessel giant cell arteritis using the new 2022 American College of Rheumatology/EULAR classification criteria: comment on the article by Ponte et al

    Arthritis and Rheumatology

  6. DNA methylation analysis identifies key transcription factors involved in mesenchymal stem cell osteogenic differentiation

    Biological Research, Vol. 56, Núm. 1

  7. E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  8. Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

  9. HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  10. Hematological Composite Scores in Patients with Inflammatory Bowel Disease

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  11. Malondialdehyde Serum Levels in Patients with Systemic Sclerosis Relate to Dyslipidemia and Low Ventricular Ejection Fraction

    Antioxidants, Vol. 12, Núm. 9

  12. Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity

    Diagnostics, Vol. 13, Núm. 20